phrykt

National Healthcare Corp (NHC): who owns it and who trades it

As of Nov 16, 2026, NHC insiders reported 22 open-market sales worth $10.4M and 1 purchase worth $175K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Emil E Hassan (Director), with $2.5M. 3 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling National Healthcare

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns NHC

249 funds and institutions reported NHC shares worth $2.2B at the end of Q2 2026, about 67% of the company. The largest holder is BlackRock, Inc. with 12.6%.

Funds and institutions (13F) 67%Everyone else 33%

10 largest owners, by share of the company

BlackRock, Inc.12.6%
Morgan Stanley Institutional Investment Advisors LLC6.6%
Dimensional Fund Advisors LP6.0%
Vanguard Portfolio Management LLC5.2%
First Trust Advisors LP4.7%
Vanguard Capital Management LLC3.5%
State Street Corp3.4%
Geode Capital Management, LLC2.4%
Renaissance Technologies LLC1.9%
Invesco Ltd.1.1%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.1.98M12.65%$418M+4%
Morgan Stanley Institutional Investment Advisors LLC1.03M6.58%$217M-1%
Dimensional Fund Advisors LP929,6925.95%$196M-2%
Vanguard Portfolio Management LLC809,2245.18%$171M+3%
First Trust Advisors LP730,5734.68%$154M+38%
Vanguard Capital Management LLC552,1363.53%$117M+0%
State Street Corp526,7323.37%$112M+7%
Geode Capital Management, LLC380,9342.44%$80.5M+18%
Renaissance Technologies LLC299,7171.92%$63.3M-11%
Invesco Ltd.175,2901.12%$37M+17%
Charles Schwab Investment Management Inc174,3351.12%$36.8M-2%
Sixth Street Partners Management Company, L.P.174,3351.12%$36.8M–
Northern Trust Corp145,1790.93%$30.7M+6%
Bank of New York Mellon Corp122,3200.78%$25.9M+2%
Systematic Financial Management LP109,0860.70%$23.1M-6%
T. Rowe Price Investment Management, Inc.107,2480.69%$22.7M–
Arrowstreet Capital, Limited Partnership96,5500.62%$20.4M+28%
Morgan Stanley93,5360.60%$19.8M-13%
American Century Companies Inc92,9330.59%$19.6M+4%
Alps Advisors Inc87,6600.56%$18.5M-44%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, NHC insiders reported $175K of open-market purchases and $10.4M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$175K
1 trades, 1 people
Sales, 12 months
$10.4M
22 trades, 9 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Sep 22, 2026
Filed Sep 23, 2026

Purchases and sales by month

$3.2M$3.2MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 22, 2026Vicki L DodsonVice presidentSale4,834$225.00$1.1MForm 4
Sep 11, 2026Brian F KiddCFOSale6,813$225.70$1.5MForm 4
Sep 10, 2026Josh A McCrearyVice presidentSale1,291$225.09$291KForm 4
Sep 10, 2026Josh A McCrearyVice presidentSale789$223.78$177KForm 4
Sep 10, 2026Josh A McCrearyVice presidentSale571$222.73$127KForm 4
Sep 10, 2026Josh A McCrearyVice presidentSale68$225.59$15.3KForm 4
Aug 28, 2026Ben Anderson Flatt SrVice presidentSale1,000$222.50$222KForm 4
Aug 25, 2026Ben Anderson Flatt SrVice presidentSale1,000$227.00$227KForm 4
Aug 25, 2026David R. GiffordDirectorSale1,779$225.42$401KForm 4
Aug 20, 2026Ben Anderson Flatt SrVice presidentSale1,000$237.00$237KForm 4
Aug 19, 2026Ben Anderson Flatt SrVice presidentSale1,000$237.18$237KForm 4
Aug 19, 2026Stephen Fowler FlattCEOSale1,500$237.08$356KForm 4
Aug 17, 2026Ben Anderson Flatt SrVice presidentSale1,000$226.00$226KForm 4
Aug 14, 2026Ben Anderson Flatt SrVice presidentSale1,000$222.11$222KForm 4
Aug 12, 2026Ben Anderson Flatt SrVice presidentSale1,000$221.21$221KForm 4
Jun 22, 2026Emil E HassanDirectorSale5,937$200.00$1.2MForm 4
Jun 16, 2026Emil E HassanDirectorSale1,563$199.98$313KForm 4
Jun 1, 2026Lisa PierceyDirectorPurchase949$184.26$175KForm 4
May 21, 2026Richard F Laroche JrDirectorSale7,500$195.14$1.5MForm 4
May 19, 2026Timothy J. ShellyVice presidentSale1,853$197.22$365KForm 4
Dec 17, 2025Timothy J. ShellyVice presidentSale2,454$139.42$342KForm 4
Nov 25, 2025Emil E HassanDirectorSale7,500$138.52$1MForm 4
Nov 21, 2025Stephen Fowler FlattCEOSale1,000$130.33$130KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Emil E HassanDirector–$2.5MJun 22, 2026
Ben Anderson Flatt SrSenior VP & CIO–$1.6MAug 28, 2026
Brian F KiddSVP, CFO–$1.5MSep 11, 2026
Richard F Laroche JrDirector–$1.5MMay 21, 2026
Vicki L DodsonSr.VP Patient Srvcs–$1.1MSep 22, 2026
Timothy J. ShellySr.VP Operations–$708KMay 19, 2026
Josh A McCrearySenior VP & General Counsel–$610KSep 10, 2026
Stephen Fowler FlattCEO, Director–$486KAug 19, 2026
David R. GiffordDirector–$401KAug 25, 2026
Lisa PierceyDirector$175K–Jun 1, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

NHC short interest

Low short interest. 4.9% of NHC shares are sold short: about 1 share in 20. Over the last 12 reports the number of shares short went up 21%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 769,712 NHC shares were sold short, 4.9% of the shares outstanding, up 1.9% from the report before. At the average daily volume of 172,979 shares, buying them all back would take about 4.5 trading days (days to cover).

Shares short, % of all shares

4.91%May 15Oct 305.47%

Days to cover

4.5May 15Oct 309.7

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026769,7124.91%+2%172,9794.5
Oct 15, 2026755,0394.82%-8%84,6248.9
Sep 30, 2026817,1605.22%+20%132,7706.2
Sep 15, 2026683,1754.36%-9%81,8618.3
Aug 31, 2026746,7994.77%-1%102,9297.3
Aug 14, 2026756,8504.83%+1%129,2545.9
Jul 31, 2026747,9744.79%+5%102,6137.3
Jul 15, 2026713,0584.57%-10%111,4196.4
Jun 30, 2026790,1135.06%+43%223,6413.5
Jun 15, 2026552,9213.54%-7%123,0124.5
May 29, 2026594,6003.81%-7%111,5195.3
May 15, 2026635,9794.07%-8%92,3696.9

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

National Healthcare company events

National Healthcare filed 14 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 6, 2026.

  1. Nov 6, 2026ResultsReleased financial results. Filing
  2. Nov 6, 2026AnnouncementNHC issued a press release on November 5, 2026, announcing its quarterly common dividend. Filing
  3. Aug 11, 2026AnnouncementNHC issued a press release on August 6, 2026, announcing its quarterly common dividend. Filing
  4. Aug 11, 2026ResultsReleased financial results. Filing
  5. Jul 1, 2026DealThe information set forth in the Introductory Note to this report and in Item 1.01 of the April 21st Current Report is incorporated by reference into this Item 2.01 to the extent such information is responsive to the disclosure requirements of Item 2.01 of Current Report on Form 8-K. The Purchase… Filing
  6. May 27, 2026AgreementNational HealthCare Corporation entered into a Credit Agreement among NHC, as borrower, certain subsidiaries of NHC, as the guarantors, the lenders from time to time party thereto, and Bank of America, N.A., as administrative agent, swingline lender and issuer of letters of credit. Filing
  7. May 15, 2026AgreementNHC/OP, L.P., a Delaware limited partnership and a wholly-owned subsidiary of National HealthCare Corporation, entered into a Purchase and Sale Agreement with National Health Corporation, a Tennessee corporation, to purchase from Seller the land, buildings, and other specified assets of Seller’s… Filing
  8. May 13, 2026VoteReported shareholder vote results. Filing
  9. May 8, 2026ResultsReleased financial results. Filing
  10. May 7, 2026AnnouncementNHC issued a press release on May 7, 2026, announcing its quarterly common dividend. Filing
  11. Apr 22, 2026AgreementNHC/OP, L.P., a Delaware limited partnership and a wholly-owned subsidiary of National HealthCare Corporation, on behalf of itself and its affiliates identified in the Agreement, each of which is a wholly-owned subsidiary of NHC (collectively, together with the Purchaser, “we,” “us,” or “our”)… Filing
  12. Feb 27, 2026ResultsReleased financial results. Filing
  13. Feb 17, 2026LeadershipThe Board of Directors of National HealthCare Corporation, upon the recommendation of the Nominating and Corporate Governance Committee of the Board and by unanimous vote of the Board, increased the size of the Board by two (2) directors to a total of nine (9) directors effective February 12, 2026… Filing
  14. Feb 13, 2026AnnouncementNHC issued a press release on February 13, 2026, announcing its quarterly common dividend. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

National Healthcare financials

Famous investors that hold NHC

3 of the 50 well-known investors we track reported holding NHC in their latest 13F filing. The largest position is Jim Simons's, worth $57.8M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 2026263,117$57.8M0.1%-12%
Israel Englander · Millennium ManagementQ3 20265,675$1.2M0.0%New
Jeremy Grantham · GMOQ3 20261,666$366K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named NHC in the last 120 days.

FiledHolderFormStake
Oct 30, 2026First Trust Portfolios L.P.13G/A4.6%
Oct 30, 2026First Trust Portfolios L.P.13G/A4.6%

Questions about National Healthcare Corp (NHC) stock

Who owns the most NHC stock?

The largest reported owner of National Healthcare Corp (NHC) is BlackRock, Inc., with 12.6% of the company. In total, 249 funds and institutions reported holding NHC at the end of Q2 2026, together about 67% of the shares. See the largest owners.

Are NHC insiders buying or selling?

In the last 12 months, NHC insiders reported 1 open-market purchase worth $175K and 22 sales worth $10.4M. The latest trade was on Sep 22, 2026. See every trade.

What is the short interest in NHC?

As of Oct 30, 2026, 769,712 NHC shares were sold short, 4.9% of the shares outstanding, up 1.9% from the report before. At the average daily volume of 172,979 shares, buying them all back would take about 4.5 trading days (days to cover). See the history.

Which famous investors hold NHC?

3 of the 50 well-known investors we track reported NHC in their latest 13F filing, including Jim Simons, Israel Englander, Jeremy Grantham. The largest position is worth $57.8M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.